The Eukaryotic Single Cell Genomics facility (ESCG), is looking for 1-2 highly qualified Research Specialists.
ESCG is a core facility at Karolinska Institutet and a national facility at Science for Life Laboratory (SciLifeLab). Based at SciLifeLab in Stockholm, the focus of ESCG is on high throughput streamlined transcriptome and genome analysis of large numbers of individual eukaryotic cells. The first vacancy is a substitute (vikariat) and the second possible position is a temporary employment.
ESCG constructs RNA and DNA sequence libraries from single-cell suspensions using state-of-the-art technologies. You will handle delicate primary cell samples, fragile RNA and sensitive instruments on a daily basis.
Your responsibilities will include all aspects of running single-cell methods, RNA-isolation and sequencing library construction, microscopy, image analysis, quality control, trouble-shooting. Methods include Smart-seq3 protocol, Chromium system from 10x Genomics and custom protocols. Additionally, you will operate liquid handling robots, qPCR/PCR, and Bioanalyzer instruments. Your work may also include to implement new single-cell methods at the facility.
Other tasks may include project coordination, user consultations, cost calculations, invoice preparations, development of laboratory protocols (SOPs), procurement, ordering, shipments, inventory, risk assessments.
You are service-minded and enjoy learning new methods. You are thorough, flexible, diligent in your laboratory work and proficient in work documentation. The position requires being able to work independently as well as in collaboration with others. You are able to work with several projects in parallel. You will work in an international team with frequent interactions with customers, therefore clear and informative communication skills, general computing proficiency, and a good knowledge of English are essential. Strong interpersonal skills will be highly valued.
To be eligible for employment as a Research Specialist, in addition to holding a Degree of Doctor, PhD, or having equivalent scientific expertise, the applicant must have demonstrated research expertise as well as have documented research experience after defending their doctoral dissertation.
- Ph.D. in molecular biology, biomedical science, biotechnology or similar discipline
- Previous work with RNA and primary cells
- Good knowledge in molecular biology techniques
- Communication in Swedish and English
- Experience with laboratory work following Good Laboratory Practice (GLP), including biosafety rules
- Method development in the molecular biology field
- Previous work with single-cell techniques
- Experience with high-throughput sample preparation of RNA and/or DNA
- Experience with laboratory automation
- Experience with data handling, programming and bioinformatics
After an overall assessment of the expertise and merits of the applicants in relation to the subject area, Karolinska Institutet will determine which of them has the best potential to contribute to a positive development of the activities at KI.
What do we offer?
A creative and inspiring environment with wide-ranging expertise and interests. Karolinska Institutet is one of the world's leading medical universities. Our vision is to pursue the development of knowledge about life and to promote a better health for all. At Karolinska Institutet, we conduct successful medical research and hold the largest range of medical education in Sweden. Karolinska Institutet is a state university, which entitles to several benefits such as extended holiday and generous occupational pension. Employees also have access to our modern gym for free and receive reimbursements for medical care.
We prefer that your application is written in English, but you can also apply in Swedish. An application must contain the following documents: Resumé, qualifications and description of planned research, presented in accordance with Karolinska Institutet's qualifications portfolio.
The application must be submitted through the Varbi recruitment system.
Applications will be screened continuously, and we may start the interview process before the last day of application.
Research Specialist In Immunology Of Chronic Viral Infections Focused On Hiv Persistence And Its Cure, Karolinska Institute, Sweden, about 13 hours ago
Do you want to contribute to better health for all? We are looking for an ambitious researcher with solid skills in immunovirology with special reference to HIV persistence to join our highly acco...
Mapping Single Cell Drug Responses In Glioblastoma Using A Multi Omics Approach, Katholieke Universiteit Leuven, Belgium, 13 days ago
(ref. BAP-2022-8) Laatst aangepast : 7/01/2022 The laboratory of Precision Cancer Medicine (www.LPCM.be) is a young team within the Translational Cell and Tissue Research Unit at the department of...
Master Thesis: Single Cell Multi Omics And Crispr Screens To Uncover The Role Of Senescent Cells In Glioblastoma And Alzheimer’s (M/F/D), Research Center for Molecular Medicine, Austria, about 5 hours ago
Master thesis: Single-cell multi-omics and CRISPR screens to uncover the role of senescent cells in glioblastoma and Alzheimer’s (m/f/d) We are recruiting an ambitious master thesis student who w...
Postdoc (3 Yr): Intracellular Notch Trafficking And Stem Cell Fate At The Grow Institute, Department Radiotherapy, Faculty Of Health, Medicine And Life Sciences, Maastricht University (UM), Netherlands, about 17 hours ago
Research topic The group of Marc Vooijs aims to unravel the tissue and context-specific regulation of Notch family proteins during normal tissue homeostasis and in cancer cells. Notch proteins are...
Mapping Single Cell Drug Responses In Glioblastoma Using A Multi Omics Approach, KU Leuven, Belgium, 14 days ago
Glioblastoma (GBM) remains the most malignant primary brain tumor. In spite of intensive treatment, current approaches are insufficiently effective to achieve major clinical benefits. GBM typicall...
Researcher In Cancer Immunology (Ref 217246), University of Oslo, Norway, 13 days ago
The position is part of a project funded by the Norwegian Cancer Society, entitled “Precision Immunotherapy for Bladder Cancer”. The aim of this project is to improve treatment of bladder cancer t...